BJ

Balasubramaniam Jayakumar

Active Director Director DIN 00301828
DIN 00301828 First appointment Mar 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Mar 2000
Shareholding value •••• Premium profile

About Balasubramaniam Jayakumar

Data last updated:

Balasubramaniam Jayakumar is a Director at Shree Amman Pharma India Private Limited (since 2022) and Director at Amman Sri Vaishnavi Chits Private Limited (since 2012). The companies operate in Pharma, Financial Services and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹211 Cr; the largest is Shree Amman Pharma India Private Limited at ₹210 Cr (FY 2025). Earlier, Balasubramaniam Jayakumar was a Director at Xan Pharma Labs Private Limited (2012–2017) and Director at Sam Overseas Trading Private Limited (2017–2018) and 2 more.

DIN 00301828
Primary Designation Director
Industry Pharma
First Appointment 09 Mar 2000
Oldest Company Age 26 yrs
Largest company Shree Amman Pharma India Private Limited · ₹210 Cr (FY 2025)
Combined revenue ₹211 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 May 20222022₹210 Cr (FY 2025)Active
Director08 Jun 20122012₹88.7 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xan Pharma Labs Private Limited U51900TN2012PTC089086
Director19 Dec 20122012₹10.6 Lakh (FY 2025)Active
Sam Overseas Trading Private Limited U74999TN2017PTC116922
Director02 Jun 20172017₹1.99 Cr (FY 2025)Active
Dukes Formulations Private Limited U24117TN2014PTC096796
Director05 Aug 20142014₹2.5 Lakh (FY 2016)Strike Off
Shree Amman Pharma Private Limited U51397TG2000PTC168011
Whole-Time Director09 Mar 20002000₹167 Cr (FY 2023)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dukes Formulations Private Limited
Shree Amman Pharma India Private Limited
Amman Sri Vaishnavi Chits Private Limited
Shree Amman Pharma Private Limited
Premium access

Shareholding and investment profile for Balasubramaniam Jayakumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balasubramaniam Jayakumar

Balasubramaniam Jayakumar currently holds 2 directorships: Shree Amman Pharma India Private Limited (Director, since 25 May 2022, revenue ₹210 Cr (FY 2025)); Amman Sri Vaishnavi Chits Private Limited (Director, since 08 Jun 2012, revenue ₹88.7 Lakh (FY 2024)).

Balasubramaniam Jayakumar was first appointed on 09 Mar 2000 as Whole-Time Director at Shree Amman Pharma Private Limited. The most recent appointment on record is 25 May 2022 at Shree Amman Pharma India Private Limited.

The 2 current companies of Balasubramaniam Jayakumar that report revenue have a combined latest revenue of ₹211 Cr: Shree Amman Pharma India Private Limited ₹210 Cr (FY 2025); Amman Sri Vaishnavi Chits Private Limited ₹88.7 Lakh (FY 2024).

Balasubramaniam Jayakumar held 4 earlier board appointments: Xan Pharma Labs Private Limited (Director, 19 Dec 2012 to 15 Feb 2017); Sam Overseas Trading Private Limited (Director, 02 Jun 2017 to 29 Sep 2018); Dukes Formulations Private Limited (Director, from 05 Aug 2014); Shree Amman Pharma Private Limited (Whole-Time Director, from 09 Mar 2000).

The current boards of Balasubramaniam Jayakumar's companies include Arvind Kumar Venkat (Shree Amman Pharma India Private Limited), Gaurav Chaturvedi (Shree Amman Pharma India Private Limited), Somu Baskaran (Shree Amman Pharma India Private Limited), Baskaran Malathy (Amman Sri Vaishnavi Chits Private Limited), Panbazhaki Jayakumar (Amman Sri Vaishnavi Chits Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available